WallStreetZenWallStreetZen

NASDAQ: NBIX
Neurocrine Biosciences Inc Stock Ownership - Who owns Neurocrine Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Neurocrine Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Leslie V. NorwalkDirector2026-05-123,810$155.01
$590.60kSell
Kyle GanoChief Executive Officer2026-02-131,210$124.12
$150.19kSell
Kyle GanoChief Executive Officer2026-02-131,385$124.12
$171.91kSell
Kyle GanoChief Executive Officer2026-02-135,378$124.12
$667.52kSell
Kevin Charles GormanDirector2026-02-132,901$124.12
$360.07kSell
Kevin Charles GormanDirector2026-02-133,024$124.12
$375.34kSell
Jude OnyiaChief Scientific Officer2026-02-131,466$124.12
$181.96kSell
Jude OnyiaChief Scientific Officer2026-02-131,452$124.12
$180.22kSell
Jude OnyiaChief Scientific Officer2026-02-1310,755$124.12
$1.33MSell
Matt AbernethyChief Financial Officer2026-02-135,378$124.12
$667.52kSell

1 of 8

NBIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBIX insiders and whales buy or sell their stock.

NBIX Shareholders

What type of owners hold Neurocrine Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P34.87%35,058,600$5.55BInsider
Vanguard Portfolio Management LLC4.70%4,726,344$748.75MInstitution
Vanguard Capital Management LLC4.49%4,511,904$714.78MInstitution
Ubs Group Ag1.21%1,221,036$193.44MInstitution
Venrock Healthcare Capital Partners LP0.74%739,900$117.21MInsider
Bryan E. Roberts0.74%739,900$117.21MInsider
Anders D. Hove0.74%739,900$117.21MInsider
Dimensional Fund Advisors LP0.71%711,762$112.76MInstitution
Bank Of New York Mellon Corp0.70%702,492$111.29MInstitution
Fiera Capital Corp0.65%651,255$103.17MInstitution

1 of 3

NBIX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBIX25.29%39.97%Net SellingNet Selling
RGC0.02%88.80%
VTRS36.17%18.44%Net SellingNet Selling
RDY6.03%26.66%
ELAN37.90%10.45%Net SellingNet Selling
View Top Pharmaceutical Stocks

Neurocrine Biosciences Stock Ownership FAQ

Who owns Neurocrine Biosciences?

Neurocrine Biosciences (NASDAQ: NBIX) is owned by 25.29% institutional shareholders, 39.97% Neurocrine Biosciences insiders, and 34.74% retail investors. Bvf Partners L P is the largest individual Neurocrine Biosciences shareholder, owning 35.06M shares representing 34.87% of the company. Bvf Partners L P's Neurocrine Biosciences shares are currently valued at $5.55B.

If you're new to stock investing, here's how to buy Neurocrine Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.